Transaction #10443 · Form 4 · 0001550701-25-000002
TENAX THERAPEUTICS, INC. · Purchase · Common Stock
TENAX THERAPEUTICS, INC. · Transacted November 17, 2025 · Filed November 19, 2025
What does this filing report?
An SEC Form 4 filing for TENAX THERAPEUTICS, INC. records a purchase involving Common Stock on November 17, 2025. The reported quantity was 5,000. The filing date is November 19, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- TENAX THERAPEUTICS, INC.
- Company CIK
- 0000034956
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 5,000
- Reported price
- 7.228 · See footnotes
- Reference value
- 36,140
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 5,000
- Ownership description
- By Spouse
- SEC acceptance time
- Nov 19, 2025, 7:01 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- MCGAULEY THOMAS ↗
Interim CFO
CIK 0001550701
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- This transaction was executed in multiple trades at prices ranging from $7.14 to $7.43. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2
- This transaction was executed in multiple trades at prices ranging from $7.17 to $7.30. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.